A student-run resource for reliable reports on the latest law and technology news
By Sarah Sorscher*, JD/MPH Candidate, Harvard Law School & Sara Crager, MD/PhD Candidate, Yale Editorial Policy Text of H.R. 1427 Summary Last week, Rep. Henry Waxman and several other representatives unveiled the latest version of a bill designed to lower the price of drugs by encouraging generic competition in biological products (“biologics”). Biologics are products derived from living processes and used to prevent, treat, or cure human illness. Most drugs, in contrast, are synthesized using chemical reactions.  Biologics include products such as vaccines, blood-derived products, antibodies, ... Read More...
Posted On Mar - 19 - 2009 Comments Off READ FULL POST
  • RSS
  • Facebook
  • Twitter
  • GooglePlay
600px-NetNeutrality_logo.svg_

The FCC’s Net Neut

By Shuli Wang - Edited by Yaping Zhang THE FCC 15-24 ...

13399-surveillance_news

White House releases

By Lan Du – Edited by Katherine Kwong Administration Discussion Draft: ...

Unknown

Federal Circuit Flas

By Patrick Gallagher Federal Circuit Affirms Denial of AT&T Motion to ...

Logo_colors_wikimedia

Wikimedia Sues NSA f

By Paulius Jurcys – Edited by Sarah O’Loughlin On March 10, ...

Photo By: MusesTouch - digiArt & design - CC BY 2.0

Florida Considers a

By Paulius Jurcys – Edited by Anton Ziajka [caption id="attachment_3781" align="alignleft" ...